A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia
ConclusionG-Clb is likely to show superior efficacy to other treatment options selected in our NMA for unfit treatment-na ïve patients with CLL.FundingF. Hoffmann-La Roche Ltd.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Drugs & Pharmacology | Leukemia | Study | Toxicology | Treanda